FDA issues draft guidance on user fees
Device Regulation Alert: Safety, Compliance and Reimbursement News, March 30, 2009
New FDA draft guidance includes user fee and user-fee refund information for 30-day notices and periodic reports, as well as modified user-fee refund provisions for modular premarket approval applications (PMAs).
The guidance identifies:
- Types of PMAs subject to user fees
- Types of PMAs that are not subject to user fees because they are expressly excluded from fees under the act
- Actions that may result in refunds of user fees that have been paid
The FDA will accept comments on the draft guidance until April 13.
Related Products
Most Popular
- Articles
-
- HIPAA Q&A: Flu shot requirement for hospital employees
- Running an effective peer review committee meeting
- HealthDataInsights posts new issues for medical necessity claims
- Sneak Peek: Effort underway to establish caseload benchmarks
- New FAQ posted on storing laryngoscope blades
- Q/A: Coding for telescopic intraocular lens
- Tip: Perform your own internal investigation prior to government audit
- HIPAA 5010 deadline extended, but threat remains, says AMA
- What does case-mix index mean to you?
- HHS task force: Consider privacy, security with text messages
- E-mailed
-
- Running an effective peer review committee meeting
- HIPAA Q&A: Flu shot requirement for hospital employees
- What does case-mix index mean to you?
- HHS task force: Consider privacy, security with text messages
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Q/A: Coding for telescopic intraocular lens
- Q/A: Correct use of modifier -PT
- Tip: Correctly code bilateral pain management procedures
- 2012 CPT code changes for ASCs: Shoulder and knee scopes and pain management
- COT basics to best
- Searched
